rhenium Re 186 etidronate
Term · Oncology and biomedicine · MLC-T-ONC-016526
An synthetic compound containing the organic phosphonate hydroxyethylidene diphosphonate (HEDP) labeled with the radioisotope rhenium Re 186. Re-186 etidronate binds to hydroxyapatite in bone, delivering a cytotoxic dose of beta radiation to primary and metastatic bone tumors. Re-186 is a beta emitter with a short half-life, a radioisotope profile that provides localized antitumor radiocytotoxicity while sparing extramedullary bone marrow tissues.
| Identifier | MLC-T-ONC-016526 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | Re-186 HEDP |
| Synonyms | Re-186 hydroxyethylidene diphosphonate; rhenium Re-186 hydroxyethylidene diphosphonate; Re 186 hydroxyethylidene diphosphonate; 186Re-etidronate; rhenium-186 HEDP |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-016526",
"term": "rhenium Re 186 etidronate",
"field": "Oncology and biomedicine",
"definition": "An synthetic compound containing the organic phosphonate hydroxyethylidene diphosphonate (HEDP) labeled with the radioisotope rhenium Re 186. Re-186 etidronate binds to hydroxyapatite in bone, delivering a cytotoxic dose of beta radiation to primary and metastatic bone tumors. Re-186 is a beta emitter with a short half-life, a radioisotope profile that provides localized antitumor radiocytotoxicity while sparing extramedullary bone marrow tissues.",
"abbreviation": "Re-186 HEDP",
"synonyms": [
"Re-186 hydroxyethylidene diphosphonate",
"rhenium Re-186 hydroxyethylidene diphosphonate",
"Re 186 hydroxyethylidene diphosphonate",
"186Re-etidronate",
"rhenium-186 HEDP"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/rhenium-re-186-etidronate/"
}
Record 14,446 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.